Botanic Healthcare® Publishes Human Clinical Data Confirming Enhanced Bioavailability of Lipomac™ Liposomal Vitamin C

Hyderabad, India | January 19, 2026.

Botanic Healthcare, a globally trusted manufacturer of science-backed nutraceutical ingredients, has announced the publication of clinical data demonstrating the superior bioavailability of Lipomac™, a clinically engineered liposomal vitamin C developed using patented DFS Technology™ .

The randomized, open-label, crossover clinical study evaluated the pharmacokinetics of Lipomac™ compared with conventional non-liposomal vitamin C in 12 healthy adult subjects. Results showed significantly higher systemic exposure following Lipomac™ supplementation, confirming enhanced absorption, improved gastrointestinal transit and prolonged vitamin C circulation.

The findings provide robust human evidence supporting Lipomac™ delivery as an effective strategy to overcome the inherent absorption limitations associated with conventional vitamin C formulations.

Clinical Study Highlight
· Randomized, open-label, cross-over design
· Conducted in 12 healthy adults
· Compared Lipomac™ liposomal vitamin C vs. standard non-liposomal vitamin C
· Demonstrated markedly higher bioavailability and systemic exposure with Lipomac™

Why Liposomal Delivery Matters

Conventional Vitamin C is highly susceptible to degradation in the digestive tract, limiting the amount that ultimately reaches systemic circulation. Liposomal delivery systems use biocompatible phospholipid vesicles to encapsulate the active ingredient, offering:

· Enhanced intestinal absorption
· Protection from chemical and enzymatic degradation
· Improved delivery into systemic circulation

Clinical confirmation reinforces liposomal technology as a validated and scalable platform for nutraceuticals requiring enhanced uptake and biological efficiency.

Advanced Delivery Powered by DFS Technology™

Lipomac™ is developed using Botanic Healthcare’s proprietary DFS Technology™ , a patented platform engineered to stabilize sensitive active ingredients, enable targeted delivery and maximize biological performance.

Lipomac™ is part of Lipsobio®, Botanic Healthcare’s advanced portfolio of liposomal ingredients spanning vitamins, minerals, nutraceuticals, and botanical actives. Lipsobio® authenticates each ingredient through Cryo-EM/TEM imaging, nanoscale structural mapping, stability and encapsulation profiling, in-vitro absorption experiments, and clinical data providing a scientific standard few can match.

Scientific Leadership Perspective
Commenting on the findings, Dr. H. N. Shivaprasad, Chief Scientific Officer, Botanic Healthcare, said:
“These findings validate the core scientific engineering behind DFS Technology™ and reinforce the measurable performance advantages of liposomal formats.”

Leadership Perspectives Mr. Gaurav Soni, Founder and Managing Director:
“Lipomac™ showcases our commitment to clinically backed innovation and strengthens our position as a science-forward partner to global nutraceutical brands.”

Mr. Madhu Krishnamani, Founder and Managing Director:
“We are proud to advance health-focused solutions grounded in evidence and designed to deliver meaningful value to consumers worldwide.”

Strengthening Evidence-Based Innovation
The publication of this clinical data further strengthens Botanic Healthcare’s growing portfolio of evidence-driven nutraceutical ingredients and underscores its commitment to translating advanced delivery technologies into clinically meaningful health solutions for global partners.

About Botanic Healthcare®
Botanic Healthcare® is one of India’s largest players in the nutraceutical industry. The company is committed to transforming well-being by providing science-backed nutraceutical ingredients, backed by decades of expertise in R&D and a strong focus on quality. Through continued innovation and strategic global partnerships, Botanic aims to unlock new growth avenues and lead the global market in the nutraceutical sector.

Visit www.botanichealthcare.net for more information